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Abstract 
  
Nogo-A and Nogo-receptor have been considered to play pivotal roles in 
controlling axonal regeneration and neuronal plasticity. We investigated the 
total distribution of Nogo-A and Nogo-receptor mRNAs in the adult rat 
central nervous system using in situ hybridization histochemistry. Nogo-A is 
abundantly expressed in both neurons and oligodendrocytes throughout the 
central nervous system. Interestingly, we could not find any neurons which 
lack Nogo-A mRNA expression, indicating that Nogo-A mRNA is 
universally expressed in all neurons. In contrast, Nogo-R mRNA expression 
was very restricted. Nogo-R mRNA was expressed in the olfactory bulb, 
hippocampus, tentia tecta, some amygdala nuclei, cerebral cortex, some 
thalamic nuclei, medial habenular, whereas we could not detect it in the 
other regions. Interestingly, we did not detect Nogo-R mRNA in 
monoaminergic neurons, which are known to have high regenerative 
capacity, in the substantia nigra, ventral tegmental area, locus caeruleus, and 
raphe nuclei. In addition, although neurons in the reticular thalamus and 
cerebellar nuclei are also known to show high capacity for regeneration, 
Nogo-R mRNA was not detected there. These data indicate that Nogo-A and 
Nogo-R mRNAs were differentially expressed in the central nervous system, 
and suggest that the lack of Nogo-R expression in a given neuron might be 
necessary to keep its high regenerative capacity.     
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Introduction 
 
 Nogo-A has been discovered as a protein in myelin, which impedes 
axonal regeneration [3], [4], [7], [18]. This protein is expressed by central 
nervous system (CNS) myelin-forming oligodendrocytes but not by 
peripheral Schwann cells [8], [11], [25], and can be observed in 
immunoelectron micrographs at the innermost adaxonal and outermost 
myelin membranes [8], [25]. This expression pattern is well coincident with 
the fact that in the adult CNS axon regeneration is highly restricted [19].  In 
addition to its localization in oligodendrocytes, Nogo-A is also expressed in 
a range of central and peripheral neurons [8], [11], [25], strongly suggesting 
that this protein has additional functions in the CNS. Nogo-A is divided into 
three regions separated by two hydrophobic segments. Its large N-terminal 
domain (N-nogo) and small C-terminal domain (C-nogo) reside in the 
cytoplasmic space, whereas a short stretch of 66 amino acids (Nogo-66) 
forms an extracellular loop. Interestingly, both N-nogo and Nogo-66 have 
been reported to inhibit axons in vitro independently [4], [5], [6].  
 Recently, Nogo-66 receptor (Nogo-R) has been identified [4], [7]. 
Transfection of Nogo-R gene into retinal ganglion cells at a developmental 
stage when they otherwise are unresponsive to Nogo-66 promotes growth 
cone collapse in response to exogenously applied Nogo-66 [4]. As Nogo-R 
is a glycosyl posphatidylinositol (GPI) anchored protein, it needs the 
interaction of p75, which is known as the receptor for the neurotrophin 
family of nerve growth factor [24]. In addition, Mi et al. have reported that a 
new protein LINGO-1 is a component of the Nogo-R/p75 signaling complex, 
and plays a role to modulate intracellular Rho activity, which is important in 
cytoskeletal regulation [15]. Although Nogo-R is not completely dependent 
on Nogo-A, the interaction of both proteins is considered to play pivotal 
roles in the inhibition of axon regeneration and other additional phenomena 
in the CNS. 
  The distributions of Nogo-A and Nogo-R have been reported using 
immunohistochemisty and in situ hybridization [4], [8], [9], [11], [12], [13], 
[21], [25], [26]. Despite the importance of these proteins in the CNS, these 
reports mainly deal with their expressions in the restricted areas. In addition, 
they are sometimes very contradictory. For example, in the cerebellum, 
Fornier et al. and Hunt et al. reported that Nogo-R mRNA was expressed in 
Purkinje neurons [4], [9], however Josephson et al. did not detect Nogo-R 
mRNA in Purkinje neurons [12]. In addition, Hunt et al. reported that 
cerebellar nuclei expressed Nogo-R mRNA [9], whereas Josephson et al. did 
not [12]. It is, thus, necessary to perform more wide and detailed 
investigations of the expression patterns of Nogo-A and Nogo-R in the adult 
rat CNS. 
 
 
 
Materials and Methods 
  
In situ hybridization 
 
   Six male Wistar rats (SLC,  Shizuoka,  Japan)  weighing 
approximately 150g were decapitated under diethylether anesthesia. All 
experiments conformed to the Guidelines for Animal Experimentation at 
Hamamatsu University School of Medicine on the ethical use of animals and 
all efforts were made to minimize the number of animals used and their 
suffering. The fresh brains and nervous tissues were quickly removed and 
immediately frozen on powdered dry ice. Serial sections  (20μm thick) 
were cut on a cryostat, thaw-mounted onto silan-coated slides, and stored at 
–80℃. After being warned to room temperature, slide-mounted sections 
were fixed in 4% paraformaldehyde in 0.1M phosphatebuffer (pH7.2) for 15 
minutes (all steps were performed at room temperature unless otherwise 
indicated), rinsed three times (5 minutes each) in 4×SSC (pH7.2) (1×SSC 
contains 0.15M sodium chloride and 0.015M sodium citrate), and 
dehydrated through a graded ethanol series (70%-100%). The sections were 
then defatted with chloroform for 5miniutes, and immersed in 100% ethanol 
(twice for 5 minutes each time) before being subjected to hybridization. 
Hybridization was performed by incubating the sections with a buffer ［4×
SSC, 50% deionized formamide, 0.12M phosphate buffer (pH7.2), 
Denhardt’s solution (Nakarai, Kyoto, Japan), 2.5% tRNA (Roche, Tokyo, 
Japan), 10% dextran sulfate (Sigma, Tokyo, Japan)］containing［35S］dATP 
(1000-1500 Ci/mmol (37- 555TBq/mmol; New England Nuclear, Boston, 
MA, USA))-labeled probes (1-2×d. p. m. /ml, 0.2ml/slide) for 24hour at 
41℃. After hybridization, the sections were rinsed in 1×SSC (pH7.2) for 
10minutes, followed by rinsing three times in 1×SSC at 55℃  for 
20minutes each time. The sections were then dehydrated trough a graded 
ethanol series (70-100%). After film exposure for 7 days at room 
temperature, the sections were coated with Kodak NBT-2 emulsion (Kodak, 
Rochester, NY, USA) diluted 1:1 with water. The sections were then exposed 
at 4℃ for 2 weeks in a tightly sealed dark box. After being developed in 
D-19 developer (Kodak), fixed with photographic fixer, and washed with tap 
water, the sections were counterstained with Thionin solution to allow 
morphological identification. 
 
Oligonucleotide probes 
 
  Two antisense oligo cDNA probes (AS1 and AS2) and a sense oligo 
cDNA probe (S, complementary to AS1) for each Nogo-A and 
Nogo-receptor were designed based on the corresponding rat sequences [3], 
[4] and synthesized commercially (Takara, Tokyo, Japan). The sequences of 
the probes are as follows: 
Nogo-A-AS1, 
GCTCTGGAGCTGTCCTTCACAGGTTCTGGGGTACTGGGGAAAGA
AGCA; 
Nogo-A-AS2, 
AGTCTTCTCTGTTATAATTTGGGCCTTCCTTTCTTCTATT;  
Nogo-A-S, 
TGCTTCTTTCCCCAGTACCCCAGAACCTGTGAAGGACAGCTCCAG
AGC; 
Nogo-R-AS1, 
GTCATGCCGGAATCTCACCATCCTGTGGCTGCACTCAAAT; 
Nogo-R-AS2, 
GCAAACAGGTAGAGGGTCATGAGTCGGCCAAGGTCCCGGA;  
Nogo-R-S, 
ATTTGAGTGCAGCCACAGGATGGTGAGATTCCGGCATGAC. 
 
 
  Computer-assisted homology searches (NCBI - BLAST) showed that each 
probe has less than 50% homology with any sequences contained in the gene 
banks. The probes were labeled at the 3’ end using [35S] dATP (1000 - 1500 
Ci/mmol (37-55.5Tbq/mmol); New England Nuclear, Boston, MA, USA) 
and terminal deoxynucleotidyl transferase (Takara, Tokyo, Japan) to obtain a 
specific activity of approximately 1.4-2.0×109 d. p. m. /μg. 
 
Control studies 
  We carried out control competition experiments for the six antisense 
probes using a 100-fold excess of one of the unlabeled probes together with 
the corresponding labeled probe, and other controls involving RNase A 
pretreatment just before hybridization.  These experiments showed no 
positive signals for any of the probes.   
 
 
Nomenclature 
   The terminology used in this report follows that of the atlas of Paxinos 
and Watson [17]. 
  
   
 
 
Results  
 
General expression patterns 
 
 To investigate the specificity of oligo cDNA probes for detection of 
Nogo-A and Nogo-receptor (Nogo-R) mRNA, in situ hybridization 
histochemisty on horizontal sections from the rat brain was performed with 
two different antisense probes (AS1 and AS2) and a sense probe (S) for each 
mRNA and the results were visualized using film autoradiography as 
negative image (Fig. 1).  For each mRNA, the two antisense probes showed 
the same hybridization pattern, and the sense probe exhibited no 
hybridization signal, indicating that the antisense probes can specifically 
recognize the corresponding transcripts. Thus, in the following experiments, 
we used the AS1 probes to detect the corresponding transcripts. 
Nogo-A mRNA was expressed intensely throughout the rat central nervous 
system (Fig. 1 A and B). Very strong Nogo-A mRNA was observed in the 
olfactory bulb, medial habenular nucleus and hippocampus. Interestingly, the 
corpus callosum also showed abundant Nogo-A mRNA expression, 
indicating its glial expression. In contrast, Nogo-R mRNA expression was 
restricted to the cortex, medial habenular nucleus, hippocampus and 
cerbellum (Fig. 1 D and E). We could not detect Nogo-R mRNA expression 
in the other regions (Fig. 1 D and E). Identification of cells expressing 
Nogo-A and Nogo-R mRNAs was based upon criteria used in our previous 
study [20]. Positive cells were divided into four categories (very strong, 
strong, moderate, and low) by visual comparison of the extent of silver grain 
accumulation. The relative intensity of the in situ signals for Nogo-A and 
Ngo-R mRNAs in the rat CNS is summarized in Table 1.   
 
Expression of Nogo-A and Nogo-R mRNAs 
 
Telencephalon. 
 
Olfactory bulb 
  Nogo-A mRNA was abundantly expressed in the olfactory bulb (Fig. 2A).  
Very strong Nogo-A mRNA expression was observed in the mitral cell layer 
and internal granular layer (Fig. 2A). The glomerular layer and external 
plexiform layer expressed Nogo-A mRNA moderately (Fig. 2A). In contrast, 
we detected Nogo-R mRNA expression only in the mitral cell layer (Fig. 
2E). 
 
Septum and nuclei of the diagonal band of Broca 
 The tenia tecta expressed both Nogo-A and Nogo-R mRNA abundantly 
(Fig. 2B and F). In addition, Nogo-A mRNA was strongly expressed in the 
medial septal nucleus, and moderately in the lateral septal nuclei and 
diagonal band of Broca (Fig. 2C), while we could not detect Nogo-R mRNA 
expression in these regions (Fig. 2G). 
 
Piriform cortex and cerebral cortex. 
  Very strong Nogo-A mRNA expression and strong Nogo-R mRNA 
expression were observed in the piriform cortex  (Fig2. B, C, F and G). 
Both Nogo-A mRNA expression and Nogo-R mRNA expression were 
abundantly observed in the cerebral cortex (Fig. 2C and G). Interestingly, 
Nogo-A mRNA expression was relatively higher in the layer V (Fig. 2C), 
whereas Nogo-R mRNA expression was relatively weaker in this layer (Fig. 
2G). 
 
Hippocampal formation. 
  Nogo-A mRNA was very strongly expressed in the pyramidal cell layer of 
CA1-3, while its expression was relatively weaker in the granular cell layer 
of the dentate gyrus (Fig. 3A). Strong Nogo-R mRNA expression was also 
seen in the pyramidal cell layer of CA1-3 and the granular cell layer of 
dentate gyrus (Fig. 3E).  
 
The amygdala and bed nucleus of the stria terminalis. 
  Nogo-A mRNA was moderately expressed in all nuclei of the amygdala, 
whereas Nogo-R mRNA expression was detected only in the lateral nucleus 
and basolateral nucleus (Fig. 3A, B, E and F). The bed nucleus of the stria 
terminalis expressed Nogo-A mRNA moderately, however we could not 
detect Nogo-R mRNA there. 
 
Basal ganglia. 
  Nogo-A mRNA was moderately expressed in the globules pallidus, and 
the caudate putamen nucleus exhibited weak Nogo-A mRNA expression 
(Fig. 2C and D). On the other hand, we could not detect Nogo-R mRNA 
expression in all nuclei of the basal ganglia (Fig. 2G and H).  
 
Diencephalon. 
Thalamus. 
  All thalamic nuclei abundantly expressed Nogo-A mRNA, with relative 
stronger expression in the anterodorsal, centromedial, reticular, and 
parafascicular nuclei (Fig. 2D, Fig. 3A and B). On the other hand, Nogo-R 
mRNA was weakly expressed in most thalamic nuclei (Fig. 2H, Fig. 3E and 
F), however we could not detect Nogo-R mRNA in the reticular thalamic 
nucleus (asterisks in Fig. 2H and 3E).  
 
Habenular complex. 
  Very strong Nogo-A mRNA expression and strong Nogo-R mRNA 
expression were observed in the medial habenula nucleus. The lateral 
habenula nucleus also exhibited moderate Nogo-A mRNA expression (Fig. 
3A and B), while we could not detect Nogo-R mRNA expression there (Fig. 
3E and F). 
 
Hypothalamus. 
  Strong Nogo-A mRNA expression was observed in the supraoptic nucleus, 
paraventricular nucleus and ventromedial hypothalamic nucleus (Fig. 3A and 
B). The other nuclei expressed Nogo-A mRNA moderately (Fig. 2D, 3A and 
B). In contrast, we could not detect Nogo-R mRNA expression in this area 
(Fig. 2H, 3E and F). 
 
Others. 
  Geniculate nuclei express both Nogo-A mRNA and Nogo-R mRNA 
moderately to weakly (Fig. 3C and G). Nogo-A mRNA was abundantly 
expressed in the subthalamus and zona incerta, whereas we did not detect 
Nogo-R mRNA expression there (Fig. 3B and F). 
 
Midbrain. 
  Strong Nogo-A mRNA expression was observed in the pars compacta of 
the substantia nigra and red nucleus (Fig. 3C), in addition moderate Nogo-A 
mRNA expression was seen in the pars reticulata of the substantia nigra, 
ventral tegmental area and central gray (Fig. 3C). On the other hand we 
could not detect Nogo-R mRNA expression in these nuclei (Fig. 3G). 
 
Pons and medulla. 
 Very strong Nogo-A mRNA was observed in the locus caeruleus and 
trigeminal mesencephalic nucleus (Fig. 4A). Strong Nogo-A mRNA 
expression was seen in the pontine nucleus and dorsal raphe (Fig. 3D). In 
addition, we observed strong Nogo-A mRNA expression in the vestibular 
nuclei and cochlear nuclei (Fig. 4A and B). Furthermore, motor nuclei, such 
as the facial nucleus (Fig. 4A and B), dorsal motor nucleus of the vagus, 
hypoglossal nucleus (Fig. 4C), expressed Nogo-A mRNA strongly. Strong 
Nogo-A mRNA expression was also seen in the external cuneate nucleus and 
lateral reticular nucleus (Fig. 4C). Moderate to weak Nogo-A mRNA 
expression was seen in the other nuclei (Fig. 4A-C), whereas we could not 
detect Nogo-R mRNA expression in these areas (Fig. 4E-G). 
 
Cerebellum. 
  The granular cell layer of the cerebellum expressed both Nogo-A and 
Nogo-R   mRNA strongly (Fig. 4A-C). Nogo-A mRNA expression was 
observed in the cerebellar nucleui (Fig. 4A and B), whereas we could not 
detect Nogo-R mRNA there (Fig. 4E and F). 
 
Spinal cord 
  The ventral horn of the spinal cord exhibited strong Nogo-A mRNA 
expression. In addition, moderate Nogo-A mRNA expression was seen in the 
dorsal horn and white mattar (Fig. 4D). On the other hand, we could not 
detect Nogo-R mRNA expression in the spinal cord (Fig. 4H).  
 
Comparison in detail 
 
Olfactory bulb. 
 Nogo-A mRNA was expressed abundantly in the glomerular layer, 
external plexiform layer, mitral cell layer and internal granular layer (Fig. 
5A). In contrast, Nogo-R mRNA was only detected in the mitral cell layer 
(Fig. 5E). Bright-field observation clearly showed that positive signals for 
Nogo-A mRNA were detected in mitral neurons and other cells, whereas 
those of Nogo-R mRNA were only detected in mitral cells (arrowheads in 
Fig. 5B and F).  
 
Corpus callosum. 
  As shown in the Fig. 5C, Nogo-A mRNA was abundantly expressed in the 
corpus callosum, whereas Nogo-R mRNA was not detected there (Fig. 5G). 
Bright-field observation showed that positive cells were small and formed 
characteristic chain-like structure (arrowheads in Fig. 5D), indicating that 
oligodendrocytes express Nogo-A mRNA.  
 
Cerebral cortex. 
 Both Nogo-A mRNA and Nogo-R mRNA were expressed abundantly in 
the cerebral cortex (Fig. 6A and B). Interestingly, relative stronger Nogo-A 
mRNA and relative weaker Nogo-R mRNA were observed in the layer V.  
Fig. 6B shows that Nogo-A mRNA was detected both in large pyramidal 
neurons (arrowheads) and small glial-like cells (arrows). In contrast, Nogo-R 
mRNA was exclusively detected in pyramidal neurons (arrowheads in Fig. 
6G), but not in glial-like cells (arrows in the Fig. 6G)  
 
Hippocampal formation. 
 Nogo-A mRNA was very strongly expressed in the pyramidal cell layer of 
the Ammon’s horn, while its expression in the granule cell layer of the 
dentate gyrus was relatively weak (Fig. 6C). Nogo-R mRNA was also 
detected in the pyramidal cell layer and granule cell layer (Fig. 6H). 
Bright-field observation showed pyramidal neurons expressed both mRNAs 
abundantly (Fig. 6D and I). Interestingly, a significant difference was 
observed in interneurons. Interneurons expressed Nogo-A mRNA 
abundantly (Fig. 6E), whereas they were devoid of Nogo-R mRNA 
expression (Fig. 6J).   
 
Cerebellum 
 Closer observation revealed that Nogo-A mRNA expression was detected 
not only in the granule cell layer, but also in the Purkinje cell layer and white 
matter (Fig. 7A), while Nogo-R mRNA was exclusively expressed in the 
granule cell layer (Fig. 7E). Bright-field observation showed that Purikinje 
cells abundantly expressed Nogo-A mRNA (arrowheads in Fig. 7B), but not 
Nogo-R mRNA (arrowheads in Fig. 7F). 
 
Spinal cord 
 Cells expressing Nogo-A mRNA were detected in both gray matter and 
white matter (Fig. 7C), while we could not detect Nogo-R mRNA in the 
spinal cord (Fig. 7G). Bright-field observation showed that Nogo-A mRNA 
expression was detected in large motor neurons (arrowheads in Fig. 7D) and 
also in small glial-like cells (arrows in Fig. 7D).  
 
 
 
 
 
 
 
 
 
DISCUSSION 
  
 To date, the distributions of Nogo-A and Nogo-R have been reported using 
immunohistochemisty and in situ hybridization [4], [8], [9], [11], [12], [13], 
[21], [25], [26]. However, these studies were performed in restricted areas, 
and sometimes the data are very contradictory. Thus, we investigated the 
total distributions of Nogo-A and Nogo-R mRNAs in the adult rat CNS. The 
present results clearly show that Nogo-A is abundantly expressed in both 
neurons and oligodendrocytes throughout the CNS, whereas Nogo-R mRNA 
is expressed in very restricted areas. Although the expression level of certain 
mRNAs generally reflects that of the translated protein, sometimes the 
presence of mRNA is not a sufficient condition for the expression of the 
corresponding protein. With this caveat in mind, the present results are 
discussed. 
 Nogo-A was first discovered as a protein in CNS myelin, indicating that 
oligodendrocytes express it. In addition, neuronal Nogo-A expression has 
been reported in some areas [8], [9], [11]. Consistent with these reports, in 
the present study, we found that Nogo-A mRNA is expressed in both 
oligodendrocytes and neurons. Interestingly, we could not find any neuron 
which lack Nogo-A mRNA expression, indicating that Nogo-A is universally 
expressed in all neurons. This ubiquitous neuronal expression suggests that 
Nogo-A is fundamentally necessary to neurons. What does Nogo-A do in 
neurons? Recently, Hunt et al. showed that in culture neurons Nogo-A 
presents at branch points, varicosities, and synapses [10]. Thus we speculate 
that neuronal Nogo-A may be involved in axonal growth, guidance, and 
interactions with other axons, although additional functions might remain to 
be elucidated. 
  In contrast to the ubiquitous Nogo-A mRNA expression, we detected 
Nogo-R mRNA in very restricted areas. Nogo-R mRNA was expressed in 
the olfactory bulb, hippocampus, tentia tecta, some amygdala nuclei, 
cerebral cortex, some thalamic nuclei, medial habenular, whereas we could 
not detect it in the other regions. These data suggest that Nogo-A/Nogo-R 
signaling is not the only mechanism to explain the absence of axonal 
regeneration in the CNS. Since N-nogo is known to function as an inhibitor 
for axonal regeneration irrespective of Nogo-R [4], [5], [6], N-nogo might 
function in such regions. Although Nogo-R expression has been reported 
previously [4], [9], [12], some discrepancies were observed among our data 
and the previous data. For example, in the cerebellum, Fornier et al. and 
Hunt et al. reported that Nogo-R mRNA was expressed in Purkinje neurons 
[9], [11], however we did not detect Nogo-R mRNA in Purkinje neurons. In 
addition, Hunt et al. reported that cerebellar nuclei expressed Nogo-R 
mRNA, whereas we could not detect it there[9]. Furthermore, Fornier et al. 
and Hunt et al. reported that Nogo-R mRNA was detected in many nuclei in 
the brain stem and spinal cord [9], [11], in contrast, we could not detect 
Nogo-R mRNA there. The discrepancy might be explained with a difference 
of in situ method. Fornier et al. and Hunt et al. used a long 
digoxigenin-labeled riboprobe [9], [11], whereas we used a short 35S-labeled 
oligonucleotide probe. The long probe might have hybridized to more 
mRNA species than a shorter probe would have.  
 In the olfactory bulb, we detected Nogo-R mRNA in mitral cells, but not in 
the periglomerular neurons, and granular neurons. Mitral cells are principal 
output (projecting) neurons, and transmit olfactory information into the 
primary olfactory cortex using glutamate as a neurotransmitter. In contrast, 
periglomerular neurons and granular neurons are mainly GABAergic and 
function as interneurons. In addition, in the hippocampus, pyramidal and 
granular neurons expressed abundant Nogo-R mRNA, while we could not 
detect it in interneurons as shown in Fig. 6J. Thus, we speculate that Nogo-R 
is not expressed in interneurons in these areas. Why do interneurons lack 
Nogo-R? In the present study, we revealed that Nogo-A is expressed 
ubiquitously. In addition, Nogo-A and Nogo-R interaction is considered to 
inhibit not only axonal regeneration but also neuronal plasticity. If a given 
neuron expresses Nogo-R, the neuron might not show its plasticity well. 
Thus, we speculate that interneurons might lack Nogo-R expression to keep 
their ability for plasticity. 
 The hypothesis that Nogo-A growth inhibition is mediated by Nogo-R is 
very fascinating. If so, neurons lacking Nogo-R expression should have high 
regenerative capacity. Monoaminergic neurons are known to have high 
regenerative capacity in the CNS [14]. Interestingly, we did not detect 
Nogo-R in related nuclei, such as the ventral tegmental area, locus caeruleus, 
and raphe nuclei, indicating that the lack of Nogo-R mRNA expression in 
monoaminergic neurons might have relations with their high regenerative 
capacity. When grafts have been implanted into the thalamus, many types of 
CNS neuron are axotomized yet more than 90 % of the CNS axons which 
regenerate into and through the grafts originate from the reticular thalamic 
nucleus, the neurons of which project to dorsal thalamic nuclei. Few 
thalamocortical projection neurons (in the dorsal thalamus) regenerate their 
axons [1], [16], [22]. Interestingly, we could not detect Nogo-R mRNA in 
neurons in the reticular thalamic nucleus, indicating again that the absence of 
Nogo-R expression might explain their high capacity for regeneration. 
Furthermore, we could not detect Nogo-R mRNA in neurons in the deep 
cerebellar nuclei, which are good at regenerating axons into nerve grafts [22], 
[23], [2]. Taken together, the lack of Nogo-R expression in a neuron might 
be necessary to keep its high regenerative capacity.   
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Figure legends 
 
Fig. 1. Expression of Nogo-A mRNA (A, B), Nogo-R mRNA (D, E) in the rat brain. Note that two antisense 
probes show the same hybridization pattern for each mRNA, and that sense probes show no hybridization 
signals (C, F). cc; corpus callosum, Cer; cerebellum, Cor; cerebral cortex, CPu; caudate-putamen, Hi; 
hippocampus,  MHb; medial habenular nucleus, OB; olfactory bulb, Th; thalamus, TT; tenia tecta. Scale 
bar = 5mm.  
 
Fig. 2. Dark-field photomicrographs showing Nogo-A mRNA (A-D) and Nogo-R mRNA (E-H) expression 
in the upper part of the rat brain. Note that the reticular thalamic nucleus is devoid of Nogo-R expression 
(asterisks in H). ac; anterior commissure, AD; anterodorsal thalamic nucleus, CA1; field CA1of Ammon’s 
horn, Cor; cerebral cortex, CPu; caudate-putamen, DB; diagonal band, DEn; dorsal endopiriform nucleus, 
fmi; forceps minor of the corpus callousm, GL; glomerular layer, GP; globus pallidus, GCL; granular cell 
layer of the olfactory bulb, LS; lateral septal nucleus, MCL; mitral cell layer of the olfactory nucleus, MS; 
medial septal nucleus, Pir; piriform cortex, Rt; reticular thalamic nucleus, TT; tenia tecta, VL; ventrolateral 
thalamic nucleus. Scale bar =1mm (A, E), 2mm (B-D, F-H).  
 
Fig. 3. Dark-field photomicrographs showing Nogo-A mRNA (A-D) and Nogo-R mRNA (E-H) expression 
in the middle part of the rat brain. Note that the reticular thalamic nucleus is devoid of Nogo-R expression 
(asterisks in H). BL; basolateral amygdaloid nucleus, CA1; field CA1 of Ammon’s horn, Cer; cerebellum, 
CG; central gray, CM; central medial thalamic nucleus, DG; dentate gyrus, DR; dorsal raphe nucleus, IC; 
inferior colliculus, MG; medial geniculate nucleus, MHb; medial habenular nucleus, PF; parafascicular 
nucleus, Pn; pontine nuclei, Po; posterior thalamic nuclear group, PV; paraventricular hypothalamic nucleus, 
R; red nucleus, Rt; reticular thalamic nucleus, SC; superior colliculus, SNC; substantia nigra, compact part, 
SNR; substantia nigra, reticular part, tfp; transverse fibers of the pons, VLL; ventral nucleus of the lateral 
lemniscus, VMH; ventromedial hypothalamic nucleus, VP; ventral posterior thalamic nucleus, VTA; ventral 
tegmental area, ZI; zona incerta. Scale bar = 2mm.  
 
Fig. 4. Dark-field photomicrographs showing Nogo-A mRNA (A-D) and Nogo-R mRNA (E-H) expression 
in the lower part of the rat brain. Note that Nogo-R mRNA is hardly detected in this region except the 
cerebellar cortex. VII; facial nucleus, X; dorsal motor nucleus of vagus, XII; hypoglossal nucleus, DH; 
dorsal horn of the spinal cord, ECu; external cuneate nucleus, IO; inferior olive, Int; interposed cerebellar 
nucleus, Lat; lateral cerebellar nucleus, LC; locus coeruleus, LRt; lateral reticular nucleus, MVe; medial 
vestibular nucleus, Sol; nucleus of the solitary tract, Sp5; spinal trigeminal nucleus, SuVe; superior 
vestibular nucleus, VC; ventral cochlear nucleus, VH; ventral horn of the spinal cord, wm; white matter. 
Scale bar = 2mm (A, B, E, F), 1mm (C, D, G, H).  
 
Fig. 5. Dark- and bright-field photomicrographs showing Nogo-A mRNA (A-D) and Nogo-R mRNA (E-H) 
expression in the olfactory bulb (A, B, E, F) and corpus callosum (C, D, G, H) of the rat brain. Note that 
Nogo-A and Nogo-R mRNA positive signals were observed on mitral cells of the olfactory bulb 
(arrowheads in A, B, E, F,), and that oligodendrocytes in the corpus callosum, expressed Nogo-A mRNA, 
but not Nogo-R mRNA (arrowheads in D, H). cc; corpus callosum, Cpu; caudate-putamen, EPL; external 
plexiform layer of the olfactory bulb, GCL; granular cell layer of the olfactory bulb, GL; glomerular layer, 
LS; lateral septal nucleus, MCL; mitral cell layer of the olfactory nucleus. Scale bar = 400μm (A, C, E, G), 
100μm (B, D, F, H). 
 
Fig. 6. Dark- and bright-field photomicrographs showing Nogo-A mRNA (A-D) and Nogo-R mRNA (E-H) 
expression in the cerebral cortex (A, B, E, F), and hippocampus (C, D, G, H) of the rat brain. Note that 
Nogo-A mRNA signals were observed on pyramidal cells (arrowheads in B) and small glial-like cells 
(arrows in B), while Nogo-R mRNA signals were observed on pyramidal cells (arrowheads in G) but could 
not on olygodendrocytes (arrows in G). Nogo-A mRNA signals were observed on internal neurons in the 
hippocampus (arrowheads in E), but Nogo-R mRNA signals were not observed (arrowheads in J). II-VI; 2-6 
cortical layers, CA1-3; field CA1-3 of Ammon’s horn, cc; corpus callosum, DG; dentate gyrus. Scale bar = 
400μm (A, C, E, G), 100μm (B, D, F, H). 
 
Fig.7. Dark- and bright-field photomicrographs showing Nogo-A mRNA (A-D) and Nogo-R mRNA (E-H) 
expression in the cerebellar cortex (A, B, E, F) and spinal cord (C, D, G, H) of the rat brain. Note that 
Nogo-A mRNA signals were observed on Purkinje (arrowheads in B), while Nogo-R mRNA signals were 
not observed on Purkinje cells (arrowheads in F). Nogo-A mRNA signals were observed on motor neurons 
(arrowheads in D) and small glial-like cells (arrows in D), while Nogo-R mRNA signals were not observed 
there. DH; dorsal horn of the spinal cord, Gr; granular layer of the cerebellum, Mol; molecular cell layer, Pu; 
Purkinje cell, VH; ventral horn of the spinal cord, wm; white matter. Scale bar = 400μm (A, C, E, G), 100
μm (B, D, F, H).
Table 1. Distribution and intensity of the in situ hybridization signals for Nogo-A, 
Nogo-R mRNAs in the rat nervous system 
 
Area and cell type             Nogo-A    Nogo-R 
 
 I . Telencephalon 
     Olfactory bulb  
       Glomerular layer             ++       n.d. 
      Mitral layer             ++++      ++ 
      Granular layer            ++++       n.d. 
     Piriform cortex                  ++++      +++ 
     Hippocampal formation 
      Ammon’s horn            ++++      +++ 
      Dentate gyrus            +++      +++ 
     Septal area 
      Tenia tecta                ++++      +++ 
      Medial septal nucleus          +++      n.d. 
      Lateral septal nucleus         ++         n.d. 
     Nucleus of the diagonal band of Broca     ++       n.d. 
     Dorsal endopiriform nucleus          +++       ++ 
     Amygdala 
      Lateral nucleus                ++          ++ 
      Basolateral nucleus            ++         ++ 
      Other nuclei                   ++        n.d. 
     Bed nucleus of the stria terminalis   ++         n.d. 
     Ventral pallidum                 ++       n.d. 
     Globus pallidus                    ++          n.d. 
     Caudate putamen                     +            n.d. 
     Nucleus accumbens                +          n.d. 
     Preoptic nuclei                     ++         n.d. 
     Claustrum                            ++         ++ 
     Cerebral cortex               +++       ++ 
II . Diencephalon 
     Thalamus 
      Anterodorsal nucleus          +++         + 
      Reticular nucleus                  +++          n.d. 
       Parafascicular nucleus          +++          + 
       Centromedial nucleus                +++          n.d. 
       Other nuclei                     ++           + 
     Geniculate nuclei                  ++      + 
     Subthalamus                       +++      n.d. 
     Zona incerta                          ++       n.d. 
     Habenular complex 
       Medial nucleus           ++++      ++ 
       Lateral nucleius          ++       n.d. 
     Hypothalamus 
      Supraoptic nucleus         +++      n.d. 
      Paraventricular nucleus        +++       n.d. 
      Ventromedial nucleus           +++     n.d. 
      Mammillary area          +       n.d. 
       Other nuclei            ++      n.d. 
III. Midbrain 
     Ventral tegmental area         ++       n.d. 
     
continued 
 
 
 
     Subatantia nigra  
      Pars compacta           +++       n.d. 
       Pars retinaculata        ++      n.d. 
     Red nucleus            +++       n.d. 
     Central gray matter      ++      n.d. 
     Nucleus of Darkschewitsch       +++     n.d. 
     Interpendicular nucleus         ++      n.d. 
IV. Pons and Medulla 
     Locus caeruleus            ++++     n.d. 
     Visual system 
       Pretectal area         ++       n.d. 
      Superior colliculus         ++      n.d. 
     Auditory system 
       Inferior colliculus        ++     n.d. 
       Cochlear nuclei              +++      n.d. 
     Vestibular nuclei                    +++         n.d. 
     Somatosensory system 
       Trigeminal mesencephalic nucleus     ++++       n.d. 
       Ttrigeminal principal nucleus        +        n.d. 
       Gracile nucleus               ++        n.d. 
       Cunate nucleus                ++         n.d. 
       External cunate nucleus        +++        n.d. 
     Nucleus of the solitary tract         ++        n.d. 
     Ambiguus nucleus                    +++          n.d. 
     Dorsal motor nucleus of the vagus         +++         n.d. 
     Oculomotor system 
       Edinger-Westphal nucleus        +++         n.d. 
       oculomotor nucleus            +++         n.d. 
     Motor trigeminal nucleus             ++          n.d. 
     Facial nucleus                      ++           n.d. 
     Hypoglossal nucleus                  +++          n.d. 
     Reticular nuclei   
       Trigmental reticular nucleus          +++         n.d. 
       Lateral reticular nucleus           +++          n.d. 
       Other nuclei                   ++         n.d. 
     Raphe nuclei 
       Dorsal raphe          +++           n.d 
       Medial raphe         +            n.d. 
       Raphe magnus                +           n.d. 
       Raphe obscurus        +            n.d. 
     Pontine nuclei                        +++          n.d. 
     Dorsal tegmental nuclei              ++            n.d. 
     Inferior olive                        ++            n.d. 
V . Cerebellum 
     Cerebellar nuclei                   +++         n.d. 
     Cortex 
       Purkinje cell                +++         n.d. 
       Granule cell                   +++           +++ 
VI. Spinal cord 
     Dorsal horn                  ++          n.d. 
     Ventral horn                   +++         n.d. 
 
Relative expression levels were estimated by visual comparison of exposed 
emulsion-coated slides: n. d., not detected; +, low; ++, moderate; +++, strong; ++++, very 
strong. 
